Allied Market Research published a report, titled, “Empty Capsules Market by Product (Gelatin Capsules and Non-Gelatin Capsules), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl Methylcellulose, and Others), Therapeutic Application (Antibiotic & Antibacterial Drugs, Vitamin & Dietary Supplements, Antacids & Anti-flatulent preparations, Cardiac Therapy Drugs, and Others), and End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the report, the global empty capsules industry generated $2.38 billion in 2020, and is expected to reach $5.23 billion by 2030, witnessing a CAGR of 8.1% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/985
Drivers, Restraints, and Opportunities
Rise in prevalence of chronic diseases, advancements in technology for development of capsules, and surge in production volumes drive the growth of the global empty capsules market. However, price fluctuations of gelatin materials and stringent regulations in the pharmaceutical industry hinder the market growth. On the other hand, surge in healthcare expenditure creates new opportunities in the coming years.
Covid-19 Scenario
- Owing to lockdown measures implemented during the Covid-19 pandemic, there were certain challenges such as disruptions in the supply chain, lack of workforce, and partial or complete closedown of factories in manufacturing of empty capsules.
- The demand from end users such as pharmaceutical manufacturers, nutraceutical manufacturers, and others reduced for a certain period as manufacturing activities were stopped. However, the demand rose steadily post-lockdown.
The Gelatin Capsules Segment To Continue Its Leadership Status During The Forecast Period
Based on product, the gelatin capsules segment accounted for the highest share in 2020, holding more than four-fifths of the global empty capsules market, and is expected to continue its leadership status during the forecast period. This is due to advancements in R&D activities in the healthcare sector and better advantages of gelatin capsules as compared to other drug delivery forms. However, the non-gelatin capsules segment is estimated to witness the highest CAGR of 9.0% from 2021 to 2030, owing to rise in demand for HPMC capsules and development of plant-derived capsule manufacturing units.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/985
The Pharmaceutical Manufacturer Segment To Maintain Its Lead During The Forecast Period
Based on end user, the pharmaceutical manufacturer segment contributed to the largest share in 2020, accounting for around two-thirds of the global empty capsules market, and is projected to maintain its lead in terms of revenue during the forecast period. This is attributed to increase in demand for chemotherapy, rise in prevalence of chronic disease, and advancements in technology in capsule manufacturing. However, the nutraceutical manufacturer segment is expected to portray the largest CAGR of 9.1% from 2021 to 2030. This is due to increase in demand for healthcare supplements, supportive initiatives are taken by the government to promote awareness about dietary supplements, and rise in number of soft gelatin capsules to encapsulate dietary supplements products.
North America To Maintain Its Dominance By 2030
Based on region, North America held the largest market share in 2020, contributing to more than one-third of the global empty capsules market, and is expected to maintain its dominance by 2030. This is due to rise in the prevalence of chronic disease such as cardiovascular disease and cancer, presence of key players for the manufacturing of empty capsules, and advancements in capsule drug delivery technology in the region. However, Asia-Pacific is estimated to witness the fastest CAGR of 9.5% from 2021 to 2030, owing to surge in the geriatric population and rise in demand for immunity booster products.
Leading Market Players
ACG Worldwide
Bright Pharma Caps
CapsCanada Corporation
Lonza Group (Capsugel)
Medi-Caps
Mitsubishi Chemical Holdings (Qualicaps)
Roxlor
Snail Pharma Industry
Suheung
Sunil Healthcare
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.